About Adenosine monophosphate deaminase deficiency
Adenosine monophosphate deaminase deficiency is a rare disease catalogued by Orphanet (ORPHA:45). It is associated with the AMPD1, AMPD3 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Adenosine monophosphate deaminase deficiency trials.
Search ClinicalTrials.gov for "Adenosine monophosphate deaminase deficiency" or filter by Orphanet code ORPHA:45 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Adenosine monophosphate deaminase deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Adenosine monophosphate deaminase deficiency. Updated daily.